New drug that can ‘double’ life expectancy of lung cancer patients approved on the NHS - Verve Times

The new drug, durvalumab, enables patients to survive for “twice as long with the disease” says the NHS. The NHS announced earlier this week that the drug can “double the overall time someone can survive with an aggressive form of lung cancer from tw

The new drug, durvalumab, enables patients to survive for twice as long with the disease says the NHS. The NHS announced earlier this week that the drug can double the overall time someone can surviv… [+3441 chars]

full article...